[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]
[e-farmacos] WHO Drug Information vol.18 no.2 2004
- From: "Canas, Martin" <macanas@netverk.com.ar>
- Date: Fri, 9 Jul 2004 12:33:20 -0300
Estimadas y estimados,
Esta disponible el ultimo numero de WHO Drug Information vol.18 no.2 2004
en la siguiente direccion:
http://www.who.int/druginformation/vol18num2_2004/DI18-2.pdf
Saludos,
Martin
Martin Canas
La Plata
(Argentina)
El contenido es el siguiente:
Aspects of Quality Assurance
Stability testing for hot and humid climates 113
Safety and Efficacy Issues
Efficacy of artesunate for emergency malaria treatment 117
Natural health products and drug interactions 120
Valdecoxib: severe cutaneous reactions 121
International Nonproprietary Names
An international role for nomenclature through INNs 123
Regulatory and Safety Action
SSRIs: behavioural and emotional changes and risk of self-harm 127
Proposed rule on combination products 128
European Medicines Agency: new name and advisory role 128
Atypical antipsychotics warning 129
Tegaserod maleate: updated precautions 129
Rotavirus vaccine ready for licensing 129
Tenofovir approved for HIV 130
Rosuvastatin: revised package insert 130
Sulphur hexafluoride: contraindicated in heart disease 131
Oxandrolone and warfarin 131
Oseltamivir: new preclinical findings 131
Muromonab: nervous system complications 132
Domperidone and unapproved use 132
Safety of Medicines
Combating counterfeit medicines 133
Current Topics
New oral rehydration solution adopted by WHO and UNICEF 138
A single oral rehydration solution for global use? 138
Principles for fixed-dose combination drug products 140
Mozambique issues compulsory license for HIV antiretrovirals 141
Improved use of medicines 141
Rapid TB diagnostic test by 2005 142
Research bioethics training 142
Consultation Document
The International Pharmacopoeia: monographs for antiretrovirals 143
Didanosine 143
ATC/DDD Classification
Final list 148
Temporary list 150
Recent Publications and Sources of Information
Specifications for pharmaceutical preparations 153
WHO model formulary 153
Guidance on risk management 153
Clinical trial fellowships 154
On-line course in medicines management 154
|